Possible Mechanism on Enhanced Blood Compatibility, Biostability, and Anticalcification of Sulfonated Polyethyleneoxide-Grafted Polyurethane by Han, Dong-Keun et al.
The Seoul Journal 0/ Medicine
Vol. 33, No.4: 317-3}6. December 199}
Possible Mechanism on Enhanced Blood Compatibility,
Biostability, and Anticalcification of Sulfonated
Polyethyl eneoxi de-G rafted Pol yu reth anet
Dong-Keun Han, Kyu-Back Lee', Jin-Wook Choi'. Cheol-Sang Kim2,
Hee-Chan Kim': Young-Ha Kim and Byoung-Goo Min'
Polymer Chemistry Laboratorl'. Korea lnstit life ofScience and Technology: P.O. Bo.Y 131. Cheongrvang, Seoul 130-650. and
Department I and lnst itutc: ol Biomedical Engineering. Seoul National Universitv College ()I' /\4edicine, Seoul /10-744. Korea
= Abstract = To investigate the correlation between blood compatibility and
biostability as well as the calcification-resistance of polymers, the surface of
polyurethane (PU) was grafted with hydrophilic polyethyleneoxide (PEO), and further
negatively charged sulfonate groups (S03) to produce PU-PEOIOOO and PU-PEOIOOO-
S03, respectively. PEO-S03 grafted PU surface showed great smoothness and high
hydrophilicity. PU-PEOIOOO-S03 was much more blood compatible than untreated PU
and PU-PEOlOOO from the results of in vitro platelet adhesion test and blood clotting
times and ex vivo occlusion times. After 6 months implantation in rats, the degree of
surface cracking and calcification on explanted PUs was decreased in the following or-
der: PU ) PU-PEOIOOO ) PU-PEOlOOO-S03, meaning that PU-PEOlOOO-S03 is most
promising as a biostable and calcification-resistant polymer. It is suggested that the
more blood compatible modified PUs are, the more biostable and calcification-resist-
ant. Such superior blood compatibility, biostability, and anticalcification of PU-PEOlOO
0-S03 might be attributed to the synergistic effect of nonadhesive and mobile PEO and
negative sulfonate acid groups. Therefore, surface-modified PU-PEO-S03is expected to
be useful for blood/tissue contacting biomedical material.
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require proper physical and mechanical proper-
ties, in vivo stability, nontoxicity, sterilizability
and biocompatibility to maintain the long-term
safety and performance of biomaterials implanted
in the biological environment.
Polyurethanes (PUs) have been widely
used in biomedical devices due to their superior
physical properties and relatively good biocom-
patibility. However, the inherent thrombogenicity
of PU remains a problem and limits greater
widespread application (Lelah and Cooper
1986). Also, in vitro and in vivo degradation
and calcification of PUs have been recently









